DANAHER CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 241 USD | +0.57% |
|
-3.60% | +4.10% |
| Apr. 12 | Leerink Partners Adjusts Danaher's Price Target to $265 From $255 | MT |
| Apr. 12 | As You Sow Files an Exempt Solicitation Statement with Securities and Exchange Commission | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Danaher Corporation is an industrial and technologic group organized around two families of products:
- medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.;
- professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc.
Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Calendar
2024-04-23
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
239.7
USD
Average target price
263.6
USD
Spread / Average Target
+10.00%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.10% | 177B | |
| +4.75% | 213B | |
| +13.43% | 134B | |
| +18.32% | 99.13B | |
| +0.11% | 63.47B | |
| +17.80% | 53.69B | |
| -4.51% | 46.36B | |
| -0.83% | 41.09B | |
| +11.48% | 39.3B | |
| +7.74% | 27.19B |
- Stock Market
- Equities
- DHR Stock
- News Danaher Corporation
- UBS Adjusts Danaher's Price Target to $306 From $294, Maintains Buy Rating
